Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Diagnos Inc V.ADK

Alternate Symbol(s):  DGNOF

Diagnos Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications, such as computer assisted retina analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time screening of large volumes of patients. It provides software-based services to assist health specialists in the detection of diabetic retinopathy and other eye-related pathologies. Its geographical areas include Canada, the United States of America, Mexico, and Chile. The Company’s subsidiaries include Diagnos Internacional SA de CV and Diagnos Healthcare (India) Private Limited.


TSXV:ADK - Post by User

Bullboard Posts
Post by InvestingWiseon Feb 22, 2017 12:00pm
167 Views
Post# 25877572

Saudi Arabia (KSA) contract with 542 hospitals = $$$ ?

Saudi Arabia (KSA) contract with 542 hospitals = $$$ ?1° let's congratulate Gary for his usual NR call and prime contact network!  On avearge, it finally works out...

2° I feel really sorry for all those bashers, trolls and guys mixing too much booze and cheese. They probably are now in a state of 'sticky fondue', trying to find their bread and apples bites in their hot pot...  :-)

3° ADK is again confirming their strong growth potential with this new agreement. 542 hospitals in a country where money flows out of oil wells is an EXCELLENT and VERY PROMISING news!  But how much shoulf we value this contract?

4° In earlier posts (or management reports -- I'll look for it...), we estimated that each exam brings 11 to 15$. KSA has 32 M citizens of which 17,65% ar diabetics = 5,648,000 million people x 11$ = 62 M$ (total sales target). Let's assume that 10% will be tested within 1-2 years, it gives 23,000 per month on 24 months, spread among 542 hospitals, e.g. 43 per hospital (quite realistic). Hence it might be possible to see 6 M$ flowing in within 2 y. or more if Diagnos can implement enough logistics in KSA to increase their screening capabilities...

Let's see how it moves forward...
Bullboard Posts